World’s first successful visualization of key coenzyme — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/04/140416172029.htm
source : http://www.sciencedaily.com/releases/2014/04/140416172029.htm
source : http://www.sciencedaily.com/releases/2014/02/140227115426.htm
source : http://www.sciencedaily.com/releases/2014/02/140226095211.htm
source : http://www.sciencedaily.com/releases/2014/02/140221103926.htm
source : http://www.sciencedaily.com/releases/2014/02/140219102323.htm
source : http://www.sciencedaily.com/releases/2014/01/140122091615.htm
The incidence figures for secondary breast cancer are based on long-term observation of 590 female patients in the German-Austrian pediatric treatment trials dating back to the years 1978 to 1995. The authors estimate that 19% of the girls treated with radiotherapy for Hodgkin’s disease develop secondary breast cancer within 30 years as a result of that therapy. …
This work, which sheds new light on the behavior of matter at the atomic scale and which could have important benefits in medicine, is published in the journal Nature. The radiotherapy currently used in nearly half of cancer treatments irradiates biological tissue using a radiation with a wide energy spectrum in order to destroy the cancerous cells. The work of the international team headed by two CNRS researchers from the Laboratoire de Chimie Physique — Matière et Rayonnement (CNRS/UPMC) should make it possible to improve the precision and quality of treatment by more finely targeting the range of energy used. …
Treatment given to shrink or eliminate a tumor before surgery is called neoadjuvant therapy. In some women with breast cancer treated with neoadjuvant therapy, no residual invasive cancer can be detected in breast tissue samples and lymph nodes removed during surgery. Emerging data suggest that these women, who are said to have had a pathologic complete response, have a greater chance of long-term survival compared with women who do not have a pathologic complete response. "Mutations in the PIK3CA gene are among the most common genetic aberrations in breast cancer," said Sibylle Loibl, M.D., professor at the German Breast Group in Neu-Isenburg, Germany. …
"We obtained impressive results in preclinical trials with parvovirus H-1 in brain tumors," says Dr. Antonio Marchini, a virologist at DKFZ…